No Vacancy!
           
 
     
Canaccord Genuity Gives Buy Rating to Teva Pharmaceutical Industries Ltd (TEVA)
Posted by Tammy Falkenburg
Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA)¡®s stock had its ¡°buy¡± rating reiterated by investment...[read article]
   
90-week data suggest sustained glucose reduction&hellip
Featured In: Eli Lilly
These new findings provide additional information about the use of empagliflozin in type 2 diabetes, and support... [read article]